// App-Quantinova.ai

: Clinicians' Perspectives on Cure in Adult Acute Lymphoblastic Leukemia (ALL) Patients with Minimal Residual Disease (MRD) - Findings from a UK Delphi Panel

Researchers

Presenter

  • David Marks

Principal Investigators

  • Wendy Gidman

  • Heather M Wieffer

  • Lirong Zhang

  • Ze Cong

  • Shweta Shah

Medical Centers

  • University of Bristol, Bristol, United Kingdom

  • PRMA Consulting Ltd, Fleet, United Kingdom

  • PRMA Consulting, Oxford, United Kingdom

  • Amgen Inc, South San Francisco, CA

  • Amgen Inc, Thousand Oaks, CA

Locations

  • United Kingdom

  • United States

Companies

  • PRMA Consulting Ltd.

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved